期刊文献+

针刺联合中药治疗脑梗死合并癫痫的效果分析 被引量:1

Analysis on the Effect of Acupuncture combined with Chinese Medicine in the Treatment of Cerebral Infarction with Epilepsy
下载PDF
导出
摘要 目的探析针刺联合豁痰息痉汤治疗脑梗死并癫痫患者的临床效果。方法回顾性分析2015年1月—2016年1月我院收治的78例脑梗死并癫痫患者的临床资料,按治疗方案不同分为对照组(30例)和研究组(48例),对照组行单纯豁痰息痉汤治疗,研究组在其基础上行针刺治疗,对比两组治疗效果以及神经功能缺损评分、SCL-90评分。结果治疗后研究组神经功能缺损评分以及SCL-90评分较对照组低,且治疗总有效率较对照组高,两组比较差异均具统计学意义(P<0.05)。结论针刺联合豁痰息痉汤治疗脑梗死并癫痫患者的临床效果显著,值得临床推广。 Objective To analyze the clinical effect of acupuncture combined with Huotan Xijing decoction in the treatment of cerebral infarction with epilepsy. Methods Clinical data of 78 patients with cerebral infarction and epilepsy from January 2015 to January 2016 in our hospital were retrospectively analyzed. According to the different treatment,they were divided into control group( 30cases) and study group( 48cases). The control group was treated with Huotan Xijing decoction. The study group received acupuncture treatment on the basis of the control group. The therapeutic effect,neural function defect scale and SCL- 90 score of the two groups were compared. Results After treatment,the neural function defect scale and SCL- 90 score of the study group were lower than those of the control group,the total effective rate of the study group was higher than that of the control group,and the difference between the two groups had statistical significance( P〈0. 05). Conclusion The acupuncture combined with Huotan Xijing decoction in the treatment of cerebral infarction with epilepsy has significantly clinical effect,and is worthy of clinical promotion.
作者 杨士杰
出处 《光明中医》 2016年第18期2684-2686,共3页 GUANGMING JOURNAL OF CHINESE MEDICINE
关键词 针刺 豁痰息痉汤 脑梗死 癫痫 Acupuncture Huotan Xijing decoction Cerebral infarction Epilepsy
  • 相关文献

参考文献5

二级参考文献42

  • 1CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee[J]. Lancet, 1996, 348:1329-1339.
  • 2Gao S, Wang YJ, Xu AD, et al. Chinese isehemic stroke subclassifieation[J]. Front Neurol, 2011, 2:6.
  • 3Fischer U, Baumgartner A, Arnold M, et al. What is a minor stroke?[J]. Stroke, 2010, 41:661-666.
  • 4Kennedy J, Hill MD, Ryckborst K J, et al. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER):a randomised controlled pilot trial[J]. Lancet Neurol, 2007, 6:961- 969.
  • 5Weimar C, Goertler M, R6ther J, et al. Systemic risk score evaluation in ischemic stroke patients (SCALA):a prospective cross sectional study in 85 German stroke units[J]. J Neurol, 2007, 254:1562- 1568.
  • 6Weimar C, Diener HC, Alberts M J, et al. The Essen stroke risk score predicts recurrent cardiovascular events:a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry[J]. Stroke, 2009, 40:350-354.
  • 7Jorgensen HS, Nakayama H, Raaschou HO, et al. Effect of blood pressure and diabetes on stroke in progression[J]. Lancet, 1994, 344:156-159.
  • 8Luitse M J, Biessels GJ, Rutten GE, et al. Diabetes, hyperglycaemia, and acute ischaemic stroke[J]. Lancet Neurol, 2012, 11:261-271.
  • 9Kruyt ND, Biessels GJ, Devries JH, et al. Hyperglycemia in acute ischemic stroke:pathophysiology and clinical management[J]. Nat Rev Neurol, 2010, 6:145-155.
  • 10Hanefeld M, Chiasson JL, Koehler C, et al. Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance[J]. Stroke, 2004, 35:1073-1078.

共引文献22

同被引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部